|
Volumn 19, Issue 3, 2001, Pages 261-265
|
Phase II trial of GM-CSF in advanced prostate cancer
a b c |
Author keywords
Androgen independent; GM CSF; Prostate cancer
|
Indexed keywords
ANDROGEN;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
PROSTATE SPECIFIC ANTIGEN;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DISEASE COURSE;
DRUG ACTIVITY;
DRUG MECHANISM;
DRUG TOLERABILITY;
HORMONAL THERAPY;
HUMAN;
HUMAN TISSUE;
MALE;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROSTATE CANCER;
SKIN IRRITATION;
TREATMENT OUTCOME;
ADENOCARCINOMA;
AGED;
GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT;
HUMANS;
MALE;
MIDDLE AGED;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
TREATMENT OUTCOME;
|
EID: 0034856873
PISSN: 01676997
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1010637105066 Document Type: Article |
Times cited : (35)
|
References (12)
|